March 2016

SAIL, a Maharatna Company, and a leading steel-making company in India with a turnover of 49350 crores (FY 2012-13) is in the process of modernizing and expanding its production units, raw material resources and other facilities to maintain its dominant position in the Indian steel market. Bokaro Steel Plant, one of the modernised integrated steel plants of SAIL employing a motivated workforce of around 18000 employees is producer of HR Coils/Sheets/Plates, CR Coils/ Sheets, GP Sheets/Coils. Bokaro Steel is working towards becoming a one-stop-shop for world-class flat steel in India.

SAIL, Bokaro Steel Plant invites online applications from energetic, dynamic medical professionals as Consultant/Specialists for its Bokaro General Hospital , which is a prestigious 910 bed hospital with state of the art equipment, recognised by NBE for DNB teaching in many specialities. Opportunities are also being offered for paramedical staff in the following disciplines for providing best healthcare facilities at Bokaro General Hospital and its Health Centres.

Post: Jr. Pharmacist Trainee S-3*  

Naticon research labs were established in 1999. It was registered as a private limited company in the year 2003. We are into manufacturing of pharmaceutical & unique herbal preparations. Business of 25 crore per year. We are the first in India to launch a prebiotic & probiotic vegetarian capsule. Recently we launched a research backed herbal preparation for pih, low foetal wt. Inadequateamneotic fluid. We will soon be launching a herbal product for regenuation of uterus after d & c. We are exporting our products to ciscontries.
1. Pharma company with special enzyme preparations of bromelain, trypsin, rutin, papain, 2. Veg capsules probiotics, veg capsules prebiotics, 3. Iron with stool softners. Herbal products for pregnancy induced hypertension, low foetal weight, low amneotic fluid.

Post: MR, ASM, RSM

International Society for Pharmacoeconomics and Outcome Research (ISPOR) Founded in 1995, ISPOR is a non-profit 501(c)(3) public organization for educational and scientific purposes, as defined by the US IRS, and a non-profit research organization under the European Commission 7 the Framework Programme. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) promotes the science of Pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes) and facilitates the translation of this research into useful information for health care decision makers to increase the efficiency, effectiveness, and fairness of health care to improve health. ISPOR has over 7300 members from 105 countries. In addition, the 69 ISPOR Regional Chapters have more than 6000 members, extending ISPOR’s outreach to over 13,300 members worldwide.

International Society for Pharmacoeconomics and Outcome Research (ISPOR) - India Andhra Pradesh Regional Chapter.
The ISPOR India - Andhra Pradesh Chapter was approved in June 14, 2012, established under the leadership of Dr. Y. Padmanabha Reddy (President – ISPOR India AP Chapter) comprising of 274 members. The Chapter focuses on developing a new approach of Pharmacy practice education from a regular curriculum wise teaching to an actual healthcare orientation /health outcome based training to maintain and improve patients quality of life and adhere to rationality use of medications. The chapter has organized one international conference and six national conferences within a span of 4 years which is well appreciated by all professional bodies of Pharmacy profession and ISPOR. The branch adages constant and novel contribution towards the evidence based learning, teaching, practice and research in pharmacy profession with global standards.